Study may lead to better outcomes for cystic fibrosis patients (VIDEO)

Chronic infection of the lung is the No. 1 cause of death in cystic fibrosis patients. In this video, Gregory Omlor, MD, director of pulmonary medicine at Akron Children’s Hospital, discusses a study being conducted by his staff that compares the relative effectiveness of 2 delivery systems for Tobramycin, an antibiotic that helps prevent lung infections in cystic fibrosis patients.